Affiliation:
1. N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Healthcare
of the Russian Federation
2. N.N. Blokhin National Medical Research Centre of Oncology of the Health Ministry of Russia
Abstract
At present, pancreaticoduodenoctomy causes the high incidence of complications. However, it is associated with an acceptable level of postoperative mortality. With this regard and taking into consideration a significant increase in survival in pancreatic cancer, it is highly relevant to study the negative functional outcomes of surgery and develop methods for their surgical prevention. The bibliographic review focuses on the features of three main postsurgical syndromes: gastric stasis, pancreatic exocrine and endocrine insufficiency. The study shows the dependence of these syndromes on pathomorphological characteristics of pancreatic stump, preservation of the pyloric, the variant of pancreatodigestive anastomosis and other features of reconstructive stage of the surgery.
Publisher
Annals of Surgical Hepatology
Subject
Gastroenterology,Hepatology,Surgery
Reference55 articles.
1. Kotelnikov A.G., Patutko Yu.I., Tryakin A.A. Zlokachestvennie opukholi podzeluchnoi zhelezi. V kn. Onkolologia. Klinicheskie rekomendacii / pod red. M.I. Davidova. – M.: Izdatelskaya gruppa RONC, 2015. – 680 s. (In Russ.)
2. Narayanan S., Martin A.N., Turrentine F.E. et al. Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death. J. Surg. Res. 2018; 231: 304 – 308 DOI: 10.1016/j.jss.2018.05.075
3. Kawaida H., Kono H., Hosomura N. et al. Surgical techniques and postoperative pancreatic fistula after pancreatic surgery. World Journal of Gastroenterology, 2019; 25 (28): 3722 – 3737. DOI: 10.3748/wjg.v25.i28.3722
4. Conroy T., Hammel P., Hebbar M. et al. FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. The New England Journal of Medicine. 2018, vol. 379, No 25, 2395 – 2406 DOI: 10.1056/NEJMoa1809775
5. Janssen Q.P., van Dam J.L., Doppenberg D. et al. FOLFIRINOX as initial treatment for localized pancreatic adenocarcinoma: a retrospective analysis by the Trans-Antlantic pancreatic surgery Consortium. JNCI J Natl Cancer Inst (2022) 00(0): djac 018, 1 – 9 DOI:10.1093/jnci/djac018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献